在产前心肌病症中肌肉心脏转录后景观
Amy Li1,2,3, Bernard Fang1, Mengbo Li4
1School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, NSW, Australia (A.L., B.F., Y.C.K., C.M., B.H., D.H., C.G.d.R., M. Larance, J.F.O., S.L.).
Circulation. Heart failure
|November 8, 2024
概括
产后心肌病 (PPCM) 涉及心肌中独特的分子变化,包括改变的蛋白质和新陈代谢. 这些发现为这种严重的心脏病提供了潜在的新治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 蛋白质组学和代谢组学
背景情况:
- 怀孕引发了显著的心血管适应,但一些妇女患上周围心肌病 (PPCM),一种心力衰竭形式.
- PPCM可以导致在怀孕晚期或产后的病态心脏扩张和心力衰竭.
- 人类心脏中PPCM的分子机制仍未得到充分探索.
研究的目的:
- 研究人类心脏中围心肌病 (PPCM) 背后的分子机制.
- 为了比较PPCM中的蛋白质和代谢物概况,与扩大心肌病 (DCM) 和非失败的心脏.
- 确定PPCM的潜在治疗点.
主要方法:
- 量化质谱法用于分析左心室组织中的蛋白质和代谢物概况.
- 从终端PPCM患者,DCM患者和非失败的捐赠者中获取样本.
- 进行了差异表达分析和基因和基因组的京都百科全书的途径分析.
主要成果:
- 两种蛋白质SBSPON和TNS3在PPCM中具有独特的下调,可能导致纤维化.
- 代谢分析显示,PPCM中同质酸盐和脱氧酸盐的含量升高,乳酸盐和氨酸的含量降低,这表明代谢中断.
- PPCM 显示甲状腺激素信号减少,增强了内分泌网膜应激,并改变了内分泌细胞形成的途径.
结论:
- 该研究确定了PPCM心肌中独特的分子特征.
- 这些分子变化涉及到细胞和代谢重塑.
- 这些发现表明,在PPCM中进行治疗干预的潜在目标.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...


